4.7 Article

Structural mechanism of TRPM7 channel regulation by intracellular magnesium

期刊

出版社

SPRINGER BASEL AG
DOI: 10.1007/s00018-022-04192-7

关键词

TRPM7; TRP channels; Magnesium; PIP2; ATP; Molecular dynamics simulations

资金

  1. Deutsche Forschungsgemeinschaft [TRR 152]
  2. NSF [1818213, 1563291]
  3. NIH [RO1NS083660]
  4. Projekt DEAL
  5. Direct For Biological Sciences
  6. Div Of Molecular and Cellular Bioscience [1818213] Funding Source: National Science Foundation
  7. Division Of Mathematical Sciences
  8. Direct For Mathematical & Physical Scien [1563291] Funding Source: National Science Foundation

向作者/读者索取更多资源

The study identifies a regulatory site in the TRPM7 channel where intracellular Mg2+ binds to control the channel activity. This reveals a new structure-function relationship in TRPM7 channels.
Zn2+, Mg2+ and Ca2+ are essential divalent cations implicated in many metabolic processes and signalling pathways. An emerging new paradigm is that the organismal balance of these cations predominantly depends on a common gatekeeper, the channel-kinase TRPM7. Despite extensive electrophysiological studies and recent cryo-EM analysis, an open question is how the channel activity of TRPM7 is activated. Here, we performed site-directed mutagenesis of mouse TRPM7 in conjunction with patch-clamp assessment of whole-cell and single-channel activity and molecular dynamics (MD) simulations to show that the side chains of conserved N1097 form an inter-subunit Mg2+ regulatory site located in the lower channel gate of TRPM7. Our results suggest that intracellular Mg2+ binds to this site and stabilizes the TRPM7 channel in the closed state, whereas the removal of Mg2+ favours the opening of TRPM7. Hence, our study identifies the structural underpinnings through which the TRPM7 channel is controlled by cytosolic Mg2+, representing a new structure-function relationship not yet explored among TRPM channels.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Pharmacology & Pharmacy

Structural basis of AMPA receptor inhibition by trans-4-butylcyclohexane carboxylic acid

Maria V. Yelshanskaya, Appu K. Singh, Chamali Narangoda, Robin S. B. Williams, Maria G. Kurnikova, Alexander I. Sobolevsky

Summary: This study characterized the interaction of trans-4-butylcyclohexane carboxylic acid (4-BCCA) with AMPA receptors, revealing it acts as a low-affinity inhibitor at specific sites in the transmembrane domain. The dynamic binding of 4-BCCA at these sites distinguishes it from other inhibitors like perampanel and ion channel blockers. Further research may explore the potential synergistic use of these inhibitors in treating epilepsy and other neurological disorders.

BRITISH JOURNAL OF PHARMACOLOGY (2022)

Article Cardiac & Cardiovascular Systems

The voltage-gated potassium channel K(V)1.3 regulates neutrophil recruitment during inflammation

Roland Immler, Wiebke Nadolni, Annika Bertsch, Vasilios Morikis, Ina Rohwedder, Sergi Masgrau-Alsina, Tobias Schroll, Anna Yevtushenko, Oliver Soehnlein, Markus Moser, Thomas Gudermann, Eytan R. Barnea, Markus Rehberg, Scott Simon, Susanna Zierler, Monika Pruenster, Markus Sperandio

Summary: This study reveals the critical role of the voltage-gated potassium channel K(V)1.3 in calcium signaling and neutrophil trafficking during acute inflammatory processes. The findings provide evidence for the involvement of K(V)1.3 in key functions of neutrophils and suggest new therapeutic approaches for treating inflammatory disorders.

CARDIOVASCULAR RESEARCH (2022)

Article Multidisciplinary Sciences

Accurate determination of solvation free energies of neutral organic compounds from first principles

Leonid Pereyaslavets, Ganesh Kamath, Oleg Butin, Alexey Illarionov, Michael Olevanov, Igor Kurnikov, Serzhan Sakipov, Igor Leontyev, Ekaterina Voronina, Tyler Gannon, Grzegorz Nawrocki, Mikhail Darkhovskiy, Ilya Ivahnenko, Alexander Kostikov, Jessica Scaranto, Maria G. Kurnikova, Suvo Banik, Henry Chan, Michael G. Sternberg, Subramanian K. R. S. Sankaranarayanan, Brad Crawford, Jeffrey Potoff, Michael Levitt, Roger D. Kornberg, Boris Fain

Summary: The main goal of molecular simulation is to accurately predict experimental observables of molecular systems, as well as to devise models for arbitrary neutral organic molecules. Researchers have successfully computed the solvation free energies of a diverse set of organic compounds using a polarizable force field fitted entirely to ab initio calculations, achieving high predictive accuracy.

NATURE COMMUNICATIONS (2022)

Article Multidisciplinary Sciences

Lung emphysema and impaired macrophage elastase clearance in mucolipin 3 deficient mice

Barbara Spix, Elisabeth S. Butz, Cheng-Chang Chen, Anna Scotto Rosato, Rachel Tang, Aicha Jeridi, Veronika Kudrina, Eva Plesch, Philipp Wartenberg, Elisabeth Arlt, Daria Briukhovetska, Meshal Ansari, Gizem Gunes Gunsel, Thomas M. Conlon, Amanda Wyatt, Sandra Wetzel, Daniel Teupser, Lesca M. Holdt, Fabien Ectors, Ingrid Boekhoff, Ulrich Boehm, Jaime Garcia-Anoveros, Paul Saftig, Martin Giera, Sebastian Kobold, Herbert B. Schiller, Susanna Zierler, Thomas Gudermann, Christian Wahl-Schott, Franz Bracher, Ali Oender Yildirim, Martin Biel, Christian Grimm

Summary: The study reveals TRPML3 as a key regulator of MMP-12 clearance by alveolar macrophages, suggesting it as a therapeutic target for emphysema and chronic obstructive pulmonary disease.

NATURE COMMUNICATIONS (2022)

Article Chemistry, Medicinal

Design, synthesis, and in vitro and in vivo characterization of new memantine analogs for Alzheimer's disease

Andreea L. Turcu, Julia Companys-Alemany, Matthew B. Phillips, Dhilon S. Patel, Christian Grinan-Ferre, M. Isabel Loza, Jose M. Brea, Belen Perez, David Soto, Francesc X. Sureda, Maria G. Kurnikova, Jon W. Johnson, Merce Pallas, Santiago Vazquez

Summary: This study discovered a series of memantine analogs and investigated their pharmacological properties and effects. Among them, compound IIc showed strong NMDAR blocking ability and had positive effects on cognition and locomotion in Caenorhabditis elegans and 5XFAD mice.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Multidisciplinary Sciences

Opening of glutamate receptor channel to subconductance levels

Maria V. Yelshanskaya, Dhilon S. Patel, Christopher M. Kottke, Maria G. Kurnikova, Alexander I. Sobolevsky

Summary: This study reveals the number of agonist binding domains required for ion channel opening and the impact of agonist binding on channel conductance in AMPA subtype ionotropic glutamate receptors. By combining structural analysis with experimental results, molecular dynamics simulations, and machine learning analysis, we found that at least two agonist binding domains are necessary for channel opening, and binding of agonist to all four domains does not guarantee maximal channel conductance.

NATURE (2022)

Article Multidisciplinary Sciences

Inhibition of NMDA receptors through a membrane-to-channel path

Madeleine R. Wilcox, Aparna Nigam, Nathan G. Glasgow, Chamali Narangoda, Matthew B. Phillips, Dhilon S. Patel, Samaneh Mesbahi-Vasey, Andreea L. Turcu, Santiago Vazquez, Maria G. Kurnikova, Jon W. Johnson

Summary: The study reveals that NMDA receptor channel blockers can access their binding site through two routes, providing insights into their mechanisms of action. This finding is important for understanding the neural signal transmission.

NATURE COMMUNICATIONS (2022)

Article Chemistry, Medicinal

Active Learning Guided Drug Design Lead Optimization Based on Relative Binding Free Energy Modeling

Filipp Gusev, Evgeny Gutkin, Maria G. Kurnikova, Olexandr Isayev

Summary: In this study, an efficient automated workflow was developed to identify compounds with the lowest binding free energy among thousands of congeneric ligands, which required only hundreds of thermodynamics integration calculations. The combination of active learning and automated machine learning allowed unbiased and efficient search for a small set of best-performing molecules. By applying this workflow to select inhibitors of the SARS-CoV-2 papain-like protease, 133 compounds with improved binding affinity, including 16 compounds with more than 100-fold improvement, were identified. The results demonstrate that the combination of active learning, automated machine learning, and free energy simulations provides a speedup of at least 20x compared to traditional expert-guided approaches.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2023)

Article Chemistry, Physical

Protein-Ligand Binding Free-Energy Calculations with ARROW-A Purely First-Principles Parameterized Polarizable Force Field

Grzegorz Nawrocki, Igor Leontyev, Serzhan Sakipov, Mikhail Darkhovskiy, Igor Kurnikov, Leonid Pereyaslavets, Ganesh Kamath, Ekaterina Voronina, Oleg Butin, Alexey Illarionov, Michael Olevanov, Alexander Kostikov, Ilya Ivahnenko, Dhilon S. Patel, Subramanian K. . R. S. Sankaranarayanan, Maria G. Kurnikova, Christopher Lock, Gavin E. Crooks, Michael Levitt, Roger D. Kornberg, Boris Fain

Summary: Protein-ligand binding free-energy calculations using molecular dynamics simulations can be effectively performed using the ARROW force field. The ARROW force field, which is based on high-level quantum mechanical calculations, accurately predicts the binding free energies of various protein-ligand systems. The predictions made by ARROW show a similar accuracy level as leading nonpolarizable force fields.

JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2022)

Article Immunology

Macrophages and glia are the dominant P2X7-expressing cell types in the gut nervous system-No evidence for the role of neuronal P2X7 receptors in colitis

Tina Jooss, Jiong Zhang, Bela Zimmer, Tanja Rezzonico-Jost, Bjoern Rissiek, Penelope Felipe Pelczar, Frauke Seehusen, Friedrich Koch-Nolte, Tim Magnus, Susanna Zierler, Samuel Huber, Michael Schemann, Fabio Grassi, Annette Nicke

Summary: Blocking or deleting the pro-inflammatory P2X7 receptor channel can reduce tissue damage and symptoms in models of inflammatory bowel disease. P2X7 receptors on enteric neurons were suggested to mediate neuronal death and associated motility changes. However, this study found that P2X7 was not detected in neurons but were dominantly expressed in glia and macrophages, which interact closely with neurons. The overexpression of P2X7 did not induce significant pathological effects.

MUCOSAL IMMUNOLOGY (2023)

Article Medicine, Research & Experimental

TRPM7 kinase is required for insulin production and compensatory islet responses during obesity

Noushafarin Khajavi, Andreas Beck, Klea Ricku, Philipp Beyerle, Katharina Jacob, Sabrina F. Syamsul, Anouar Belkacemi, Peter S. Reinach, Pascale C. F. Schreier, Houssein Salah, Tanja Popp, Aaron Novikoff, Andreas Breit, Vladimir Chubanov, Timo D. Mueller, Susanna Zierler, Thomas Gudermann

Summary: TRPM7 kinase is a potential regulator of insulin synthesis, beta cell dynamics, and glucose homeostasis. Its deletion disrupts insulin secretion and leads to glucose intolerance.

JCI INSIGHT (2023)

Article Multidisciplinary Sciences

Structural mechanisms of TRPM7 activation and inhibition

Kirill D. Nadezhdin, Leonor Correia, Chamali Narangoda, Dhilon S. Patel, Arthur Neuberger, Thomas Gudermann, Maria G. Kurnikova, Vladimir Chubanov, Alexander I. Sobolevsky

Summary: The transient receptor potential channel TRPM7 is a crucial regulator of divalent cation balance in the body, impacting various biological processes such as embryonic development, immune responses, and cell functionalities. It is linked to neuronal and cardiovascular disorders as well as tumor progression, highlighting its potential as a drug target. Using cryo-EM, functional analysis, and molecular dynamics simulations, researchers have unraveled two distinct structural mechanisms behind TRPM7 activation through gain-of-function mutations and the agonist naltriben. These mechanisms exhibit different conformational dynamics and involve different domains. Additionally, the study identifies a binding site for potent and selective inhibitors that stabilize the closed state of TRPM7, paving the way for the development of drugs targeting TRPM7-related channelopathies.

NATURE COMMUNICATIONS (2023)

暂无数据